Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism
- PMID: 1501641
- DOI: 10.1016/0166-6851(92)90023-d
Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism
Abstract
An arsenical resistant cloned line of Trypanosoma brucei brucei was derived from a parent sensitive clone by repeated selection in vivo with the pentavalent melaminophenyl arsenical, sodium melarsen. The melarsen-resistant line was tested in vivo in mice against a range of trypanocidal compounds and found to be cross-resistant to the trivalent arsenicals, melarsen oxide, melarsoprol and trimelarsen (33, 67 and 122-fold, respectively). A similar pattern of cross-resistance was found in vitro using a spectrophotometric lysis assay (greater than 200-fold resistance to melarsen oxide and greater than 20-fold resistance to both trimelarsen and melarsoprol). Both lines were equally sensitive to lysis by the lipophilic analogue phenylarsine oxide in vitro, suggesting that the melamine moiety is involved in the resistance mechanism. Although trypanothione has been reported to be the primary target for trivalent arsenical drugs [1], levels of trypanothione and glutathione were not significantly different between the resistant and sensitive lines. Statistically significant differences were found in the levels of trypanothione reductase (50% lower in the resistant clone) and dihydrolipoamide dehydrogenase (38% higher in the resistant clone). However, the Km for trypanothione disulphide, the Ki for the competitive inhibitor Mel T (the melarsen oxide adduct with trypanothione) and the pseudo-first order inactivation rates with melarsen oxide were the same for trypanothione reductase purified from both clones. The melarsen-resistant line also showed varying degrees of cross-resistance to the diamidines: stilbamidine (38-fold), berenil (31.5-fold), propamidine (5.7-fold) and pentamidine (1.5-fold). Cross-resistance correlates with the maximum interatomic distance between the amidine groups of these drugs and suggests that the diamidines and melaminophenyl arsenicals are recognised by the same transport system.
Similar articles
-
Trypanothione is the primary target for arsenical drugs against African trypanosomes.Proc Natl Acad Sci U S A. 1989 Apr;86(8):2607-11. doi: 10.1073/pnas.86.8.2607. Proc Natl Acad Sci U S A. 1989. PMID: 2704738 Free PMC article.
-
Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals.Exp Parasitol. 1991 Feb;72(2):205-15. doi: 10.1016/0014-4894(91)90138-m. Exp Parasitol. 1991. PMID: 1849084
-
The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei.Mol Biochem Parasitol. 1992 Jul;53(1-2):223-31. doi: 10.1016/0166-6851(92)90024-e. Mol Biochem Parasitol. 1992. PMID: 1501642
-
The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes.Parasitol Today. 1999 Apr;15(4):136-40. doi: 10.1016/s0169-4758(99)01414-3. Parasitol Today. 1999. PMID: 10322334 Review.
-
Trypanothione metabolism and rational approaches to drug design.Biochem Soc Trans. 1990 Oct;18(5):717-20. doi: 10.1042/bst0180717. Biochem Soc Trans. 1990. PMID: 2083656 Review. No abstract available.
Cited by
-
In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors.Antimicrob Agents Chemother. 1996 Jun;40(6):1448-53. doi: 10.1128/AAC.40.6.1448. Antimicrob Agents Chemother. 1996. PMID: 8726018 Free PMC article.
-
Predominance of duplicative VSG gene conversion in antigenic variation in African trypanosomes.Mol Cell Biol. 1999 Sep;19(9):5839-46. doi: 10.1128/MCB.19.9.5839. Mol Cell Biol. 1999. PMID: 10454531 Free PMC article.
-
Phenotypic analysis of trypanothione synthetase knockdown in the African trypanosome.Biochem J. 2005 Oct 15;391(Pt 2):425-32. doi: 10.1042/BJ20050911. Biochem J. 2005. PMID: 16008527 Free PMC article.
-
Arsenic Toxicity: Molecular Targets and Therapeutic Agents.Biomolecules. 2020 Feb 4;10(2):235. doi: 10.3390/biom10020235. Biomolecules. 2020. PMID: 32033229 Free PMC article. Review.
-
Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-alpha-difluoromethylornithine and standard trypanocides.Antimicrob Agents Chemother. 1994 Mar;38(3):563-9. doi: 10.1128/AAC.38.3.563. Antimicrob Agents Chemother. 1994. PMID: 8203855 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
